PracticeUpdate: Conference Series | ADC 2018
First page
Table of contents
Next page
Last page
National Diabetes Registry to Analyze Clinical Benefits of Subsidized CGM
4
Australasian Diabetes Congress 2018 Highlights
4
‘Problematic Hypoglycemia in Adults With T1D can be avoided
6
Can Oral Insulin Delay Progression to T1D?
8
Update on Intranasal Insulin Trial II (INIT II) to Prevent Type 1 Diabetes
8
Preventing Type 1 Diabetes: What We Know
10
Once-Weekly Dulaglutide Noninferior to Once-Daily Liraglutide in Patients With Type 2 Diabetes
10
Is Targeting Mitochondrial Dysfunction Worth Considering as a Prevention Strategy for Kidney Disease in T1D?
10
Clinical Islet Transplantation in Australia
10
Research Uncovers Potential Role of Gut Research Uncovers Potential Role of Gut
14
Biodegradable Temporising Matrix as an Alternative Intracutaneous Site for Islet Transplantation
14
CVD-REAL 2: SGLT2 Inhibitors Associated With Lower CV Risk vs Other Glucose-Lowering Drugs
16
Adding Liraglutide to Standard of Care Lowers Risk of Glycemic Deterioration in T2D Patients at High CV Risk
16
‘There Is More to Neuropathy Than Hyperglycemia Alone in T2D’
18
Made with
FlippingBook
- Online Brochure Maker